High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

Semaglutide is a generic medication. Its brand names are approved for the treatment of type 2 diabetes and obesity. Compounded semaglutide is not FDA-approved, could come with risks, and may lead ...

Noom plans to offer a compounded formulation of Novo Nordisk’s (NVO) semaglutide at discount prices as part of a new ...

A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...